PFPooya Faranoush

Pooya Faranoush

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Pooya Faranoush has a total of 184 co-authors. Here are the top co-authors by number of shared publications:

  • Negin Sadighnia

    Pediatric Growth and Development Research Center, Institute of Endocrinology Iran University of Medical Sciences, Tehran, Iran

    11 shared publications
  • Mohammad Faranoush

    Pediatric Growth and Development Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran

    8 shared publications
  • Ali Elahinia

    Pediatric Growth and Development Research Center Institute of Endocrinology and Metabolism, Iran University of Medical Sciences Tehran Iran

    6 shared publications
  • Mohammad Reza Foroughi-Gilvaee

    Pediatric Growth and Development Research Center, Institute of Endocrinology Iran University of Medical Sciences, Tehran, Iran

    6 shared publications
  • Mohammad Faranoush

    Pediatric Growth and Development Research Center, Institute of Endocrinology, Iran University of Medical Sciences, Tehran, Iran

    5 shared publications
  • Afsoon Zandi

    Department of Otolaryngology, Head & Neck Surgery, Taleghani Hospital Shahid Beheshti University of Medical Sciences Tehran Iran

    4 shared publications

Latest Publications

  • Open Access

    Insights into retinoblastoma pathogenesis: unraveling RB1, N-MYC and miRNA profiles

    by Mohammad Faranoush, Fatemeh Khesali, Pooya Faranoush, Mohammad Reza Foroughi-Gilvaee, Parisa Shams, Negin Sadighnia, Seyyed Amir Yasin Ahmadi, Dorsa Fallah Azad, Reza Nekouian

    Objective: Retinoblastoma is the most common paediatric intraocular malignancy, originating in neural retina germ cells. Early diagnosis is crucial for survival and eye preservation. This study analyses gene expression and specific microRNAs (miRNAs) in patients with retinoblastoma to enhance early diagnosis, prognosis and treatment strategies. Methods: This study examined gene and miRNA expression in 18 patients with retinoblastoma and 10 healthy individuals. Peripheral blood samples were collected from all participants, and patient demographics were recorded. The analysis was performed using real-time PCR targeting the RB1 and N-MYC genes, along with the miRNAs miR-125-5p, miR-221-3p and miR-519-3p. Results: The patient group consisted of 18 participants (9 males, 9 females), aged between 2 and 6 years (mean±SD: 4.8±1.33 years), with a mean diagnosis age of 3.01±1.37 years. All participants were followed for 3 years, with no fatalities. The control group comprised 10 participants (4 males, 6 females), aged 2–8 years (mean±SD: 5.01±1.77 years). 11 patients underwent enucleation due to tumour progression: 3 right eyes and 8 left eyes. Gene expression analysis showed significant downregulation of miR-125-5p, miR-519-3p and NMYC in the retinoblastoma group. RB1 downregulation and miR-221-3p upregulation were noted in most patients, but without significant associations. Conclusion: miRNAs, along with RB1 and N-MYC genes, may serve as predictive and prognostic biomarkers in retinoblastoma. While previous studies have highlighted the impact of certain miRNAs on survival and clinical outcomes, our study is limited by a small sample size and lack of strong statistical correlations. Large-scale studies are needed to validate these preliminary findings and clarify their clinical significance. Understanding the role of miRNAs in cancer biology could improve retinoblastoma mechanism insights and patient care.

  • Open Access

    Delving Into Retinoblastoma Genetics: Discovery of Novel Mutations and Their Clinical Impact: Retrospective Cohort Study

    by Mohammad Faranoush, Masood Naseripour, Pooya Faranoush, Zeinab Davoodi‐Moghaddam, Alireza Jahandideh, Negin Sadighnia, Delbar Daneshjou, Parisa Shams, Ahad Sedaghat, Reza Mirshahi, et al.

    Background: Retinoblastoma (Rb) is a rare intraocular malignancy that originates in the retina of children under 5 years of age. Approximately one‐third of children diagnosed with retinoblastoma are associated with germline mutations in one of the RB1 alleles. In this study, we aim to identify RB1 mutations in retinoblastoma patients using Sanger sequencing in combination with multiplex ligation‐dependent probe amplification (MLPA). Method: The genomic DNA of 167 Rb patients was isolated from peripheral blood and their clinical information was extracted from medical records. The mutations in the RB1 gene were identified through PCR sequencing. Negative results from the PCR sequencing were further analyzed using MLPA reactions. Results: RB1 mutations were identified in 56 of the 167 (33.5%) patients. The common mutation types were frameshift mutations ( n = 19), followed by nonsense ( n = 20), splicing ( n = 8), missense ( n = 5), and whole exon deletion ( n = 2). The overall survival rate was 98.2%, with an average follow‐up duration of 59 months. Moreover, germline RB1 mutation's correlation with enucleation rates is less pronounced in unilateral cases (12.1%) compared to bilateral cases (65.5%). A total of 13 novel mutations have been identified, of which four are specifically associated with enucleation. Conclusion: This study provides a comprehensive analysis of RB1 germline mutations in a group of cases with Rb, leading to the identification of 13 novel mutations in Rb patients at a referral center in Iran. We expect that our findings will yield valuable insights to inform the management and genetic counseling of Rb patients, as well as their relatives who are at a higher risk.


  • Open Access

    A Comparative Study on the Impact of FIV and FeLV Infection on the Ocular Microbiota in Persian Cats: Insights From Co‐Infection and Single Infections

    by Ghazal Aftab, Parastou Arab, Pooya Faranoush

    Background: The ocular microbiome of cats infected with feline immunodeficiency virus (FIV) or feline leukemia virus (FeLV) might differ from that of healthy cats. This study aimed to examine and compare the conjunctival bacterial and fungal flora in these groups. Methods: Bacterial and fungal cultures were conducted from the conjunctiva of 80 Persian cats, categorized into four groups: normal, FIV‐infected, FeLV‐infected, and co‐infected with both FIV and FeLV. PCR assays confirmed the presence of FIV, FeLV, Chlamydia , and Mycoplasma . The microbiological analysis was compared across the different. Results: The conjunctival bacterial flora of normal cats was predominantly Gram‐positive, with Staphylococcus species as the most common isolates. Escherichia coli was absent in the normal group but present in all infected groups, with the highest prevalence in the co‐infected group (17.5%). Co‐infection with FIV and FeLV led to a distinct microbiota with Streptococcus agalactiae , Corynebacterium renale , Fusarium , and Aspergillus brasiliensis exclusively found in this group. Conclusions: The co‐infection of FIV and FeLV significantly alters the conjunctival microbiome, promoting the colonization of specific opportunistic pathogens. These findings may influence the clinical management of cats with these viral infections, especially in combination, and may create a more favorable environment for the growth of certain bacteria and fungi in the conjunctiva.

  • Open Access

    ATP‐Binding Cassette Transporter Genes and microRNAs in Pediatric B‐Cell ALL: Expression Insights

    by Reza Nekouian, Pooya Faranoush, Fatemeh Khesali, Parisa Shams, Mohammad Reza Foroughi‐Gilvaee, Negin Sadighnia, Dorsa Fallah Azad, MohammadAli Ehsani, Mohammad Faranoush

    Background: Acute lymphocytic leukemia (ALL), characterized by uncontrolled growth of abnormal lymphocytes, predominantly affects children. Genetic analysis focusing on genes and microRNAs reveals important information about the biology of ALL, enabling accurate diagnosis and treatment. This study examines gene and microRNA expression in B cell ALL to improve early diagnosis and personalized treatment.Methods: Bone marrow samples were collected from patients both before and after the induction phase of chemotherapy. Comprehensive diagnostic techniques including flow cytometry, molecular assays, real‐time PCR for common translocations, karyotyping, and complete blood count (CBC) analysis were employed. These methods were utilized to determine the type and risk assessment of ALL, identify specific gene and microRNA expressions, and measure blood cell counts.Results: The study comprised 12 patients, all under the age of 18. Post‐treatment RT‐PCR analysis revealed significant reductions in the expression of the ABCB1 gene, miR‐129‐5p, and miR‐9‐5p following the induction phase of chemotherapy. Karyotype analysis indicated that two patients were hypodiploid; unfortunately, both of these patients did not survive.Conclusion: MicroRNAs and ABC genes serve as predictive and prognostic biomarkers in Acute Lymphoblastic Leukemia (ALL) and should be carefully reconsidered. It is more accurate to state that while microRNAs and ABC genes may potentially influence treatment response in ALL, further research is crucial to fully understand their roles in determining treatment outcomes.


  • Open Access

    Clinical Outcomes of Pediatric Cancer Patients with COVID-19: A Cross-Sectional Study

    by Yasaman Arian, Pooya Faranoush, Fahime Ehsanipour, Negin Sadighnia, Ali Elahinia, Mohammad Faranoush

    Background: Considering the widespread COVID-19 pandemic and its impact, especially on children, particularly those with cancer, in terms of transmission risk, mortality, and the occurrence of the disease based on various studies in different countries, we decided to conduct this study to improve the care of children with cancer regarding COVID-19. Materials and Methods: A descriptive cross-sectional study with a confirmed diagnosis of COVID-19 consisted of obtaining 20 mL of blood samples from the participants in a random manner. Diagnostic examinations, including CT scans, chest X-rays, and a range of hematologic and blood tests, such as complete blood count, ESR, CRP, and D-Dimer, were performed on all patients. Results: This study contains 26 males and 12 females. The mean age of the patients was 3.81 ± 6.35 years. The majority of cancer patients with COVID-19 were diagnosed with Acute Lymphoblastic Leukemia (ALL) (47.7%). The most common symptoms of COVID-19 in the patients were fever (73.7%), cough (39.5%), and nausea/vomiting (21.1%). 40.4% of the patients had pathological findings suggestive of COVID-19 on their chest CT scans. 60.52% of the patients had an elevated Erythrocyte Sedimentation Rate (ESR), and 73.68% had an elevated C-reactive protein (CRP) level. Conclusion: Despite the outcomes of COVID-19 in most children with cancer in this study, children with cancer still experience risks from COVID-19, and it is unclear how delays and interruptions in cancer treatment and direct damage from the virus may impact long-term outcomes in these patients.


  • Emerging Technologies in Medicine: Artificial Intelligence, Robotics, and Medical Automation

    by Mehdi Rezaei, Shafagh Saei, Soheila Jafari Khouzani, Mahshid Esmaielzade Rostami, Maryam Rahmannia, Amir Masood Rafie Manzelat, Mahmonir Bayanati, Sina Rasti, Yasamin Rajabloo, Hamed Ghorbani, et al.


  • Artificial Intelligence in Cancer Care: From Diagnosis to Prevention and Beyond

    by Masoud Farrokhi, Amir Moeini, Fatemeh Taheri, Mehrdad Farrokhi, Maryam Mostafavi, Alireza Khodaei Ardakan, Saeedeh Shirdel, Parisa Jafari Khouzani, Soheila Jafari Khouzani, Mahsa Jafari Khouzani, et al.


  • Cover Image, Volume 6, Issue 10

    by Mohammad Faranoush, Pooya Faranoush, Iraj Heydari, Mohammad Reza Foroughi‐Gilvaee, Azita Azarkeivan, Ali Parsai Kia, Negin Sadighnia, Ali Elahinia, Afsoon Zandi, Mohammad Reza Rezvany, et al.

    The cover image is based on the Research Article Complications in patients with transfusion dependent thalassemia: A descriptive cross‐sectional study by Mohammad Faranoush et al., https://doi.org/10.1002/hsr2.1624

  • Open Access

    Complications in patients with transfusion dependent thalassemia: A descriptive cross‐sectional study

    by Mohammad Faranoush, Pooya Faranoush, Iraj Heydari, Mohammad Reza Foroughi‐Gilvaee, Azita Azarkeivan, Ali Parsai Kia, Negin Sadighnia, Ali Elahinia, Afsoon Zandi, Mohammad Reza Rezvany, et al.

    Background and Aims: One of the most common hemoglobinopathies globally related to blood transfusion and iron overload in the body is thalassemia syndrome. Increasing ferritin levels can cause severe damage to the patient's body organs. This study aims to evaluate the complications of iron overload on vital body organs in patients with transfusion‐dependent beta‐thalassemia.Methods: This descriptive cross‐sectional study was performed in Iran University of Medical Sciences Hospitals on patients with a beta‐thalassemia major with frequent blood transfusions. To evaluate the effect of iron overload on vital body organs, hematologic and blood analysis, echocardiography with measurement of pulmonary artery pressure (PAP) and ejection fraction (EF) tests, bone densitometry, and audiometric tests were performed for all patients.Results: Of the 1010 patients participating in this study, 497 (49%) were males, 513 were (51%) females aged 5–74 years, and the majority of participants (85%) were over 20 years old. This study demonstrated that increasing ferritin levels had no notable correlation with sex, cholesterol, low‐density lipoprotein, parathyroid hormone, T4, and aspartate aminotransferase. However, elevating ferritin levels had significant correlations with increasing triglyceride, phosphorus, thyroid stimulating hormone, alkaline phosphatase, alanine transaminase, and PAP levels, age, hearing disorders, splenectomy, osteoporosis, and decreasing high‐density lipoprotein, body mass index, calcium, and EF levels.Conclusion: Improvement in beta‐thalassemia patients' survival and quality of life can be due to multidisciplinary care in a comprehensive unit through regular follow‐up and early complication detection.


    • 27 September 2023

    Guideline for the diagnosis and treatment of diabetes mellitus in patients with transfusion-dependent thalassemia

    by Mohammad E. Khamseh, Mojtaba Malek, Nahid Hashemi-Madani, Fariba Ghassemi, Neda Rahimian, Amir Ziaee, Mohammad Reza Foroughi-Gilvaee, Pooya Faranoush, Negin Sadighnia, Ali Elahinia, et al.